S-Quatre Corporation
- Biotech or pharma, therapeutic R&D
S-Quatre is a clinical stage biotech company developing SQ-SHED (Stem cells from Human Exfoliated Deciduous teeth), allogeneic stem cells derived from the dental pulp of baby teeth to treat cerebral palsy, osteonecrosis of the femoral head, spinal cord injury, brain cancer, and other intractable conditions. S-Quatre has a proprietary large-scale manufacturing platform for SQ-SHED, while also advancing the clinical trial in collaboration with the academic institution in Japan.